Cellebrite: 3 Key Takeaways for Long-Term Investors

Cellebrite’s annual recurring revenue rose 20% year over year to $528.5 million in the third quarter of 2026. Its new Genesis investigative AI product generated $2 million in annual recurring revenue in its first full quarter, while adoption of its Inseyets platform reached 75% of customers. The company plans to move its legal domicile to the United States in the first half of 2027.